Synthetic lethality in the context of radiosensitization was also demonstrated in p53-mut glioma cell lines, or cell lines with other checkpoint defects, which were sensitized to radiation by ATM inhibition, in contrast to wild-type p53 lines, which showed less effect of the inhibitor [81]. The gene discussed is ATM; the disease is central nervous system cancer.